CPT1C

Chr 19AD

carnitine palmitoyltransferase 1C

Also known as: CATL1, CPT I-C, CPT1-B, CPT1P, CPTI-B, CPTIC, SPG73

This gene encodes a member of the carnitine/choline acetyltransferase family. The encoded protein regulates the beta-oxidation and transport of long-chain fatty acids into mitochondria, and may play a role in the regulation of feeding behavior and whole-body energy homeostasis. Alternatively spliced transcript variants encoding multiple protein isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.691 OMIM phenotype
Clinical SummaryCPT1C
🧬
Gene-Disease Validity (ClinGen)
hereditary spastic paraplegia · ADLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 226 VUS of 436 total submissions
📖
GeneReview available — CPT1C
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.69LOEUF
pLI 0.000
Z-score 3.20
OE 0.49 (0.350.69)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.31Z-score
OE missense 0.83 (0.770.91)
419 obs / 501.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.49 (0.350.69)
00.351.4
Missense OE?0.83 (0.770.91)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 22 / 45.2Missense obs/exp: 419 / 501.9Syn Z: -0.69

This gene — mechanism propensity

DN
0.7229th %ile
GOF
0.6052th %ile
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median · 1 literature citation
GOF1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNWe also observed a reduction of mean (SD) lipid droplets in primary cortical neurons isolated from Cpt1c−/− mice as compared with wild-type mice (1.0 [0.12] vs 0.44 [0.05]; P < .001), suggesting a dominant negative mechanism for the mutation.1
GOFCarnitine palmitoyltransferase-1c gain-of-function in the brain results in postnatal microencephaly2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

436 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic9
VUS226
Likely Benign156
Benign16
Conflicting11
8
Pathogenic
9
Likely Pathogenic
226
VUS
156
Likely Benign
16
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
7
1
0
0
8
Likely Pathogenic
7
2
0
0
9
VUS
9
202
11
4
226
Likely Benign
1
12
51
92
156
Benign
0
2
6
8
16
Conflicting
11
Total2421968104426

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

12 pathogenic / likely-pathogenic (of 17) ClinVar copy-number / structural variants overlap CPT1C — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CPT1C · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →